Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Hashimoto

Showing results (51-60 of 271) with videos related to

Pageof 28
Sort By:
Journal of Neuroscience Research|October 23, 2002
Death and survival of neuronal cells exposed to Alzheimer's insultsTakako Niikura, Yuichi Hashimoto, Hirohisa Tajima, et al.
Bioorganic & Medicinal Chemistry|January 7, 2020
Luciferase-based HMG-CoA reductase degradation assay for activity and selectivity profiling of oxy(lano)sterolsIkuya Sagimori, Hiromasa Yoshioka, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|January 26, 2020
Phosphine boranes as less hydrophobic building blocks than alkanes and silanes: Structure-property relationship and estrogen-receptor-modulating potency of 4-phosphinophenol derivativesHiroki Saito, Yuichiro Matsumoto, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2011
Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related α-glucosidase inhibitors and liver X receptor antagonistsKazunori Motoshima, Kazuyuki Sugita, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|April 26, 2011
Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivityKazunori Motoshima, Minoru Ishikawa, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|April 3, 2012
Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2Takashi Misawa, Hisamitsu Hayashi, Yuichi Sugiyama, et al.
Biochemical and Biophysical Research Communications|February 27, 2010
TAG-1 is an inhibitor of TGFbeta2-induced neuronal death via amyloid beta precursor proteinNobuyuki Tachi, Yuichi Hashimoto, Mikiro Nawa, et al.
Chemical Communications (Cambridge, England)|September 20, 2008
Sequence-specifically platinum metal deposition on enzymatically synthesized DNA block copolymerAya Tanaka, Yasutaka Matsuo, Yuichi Hashimoto, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonistsKazunori Motoshima, Minoru Ishikawa, Kazuyuki Sugita, et al.
Bioorganic & Medicinal Chemistry|July 9, 2013
Structure-activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effectFumika Karaki, Kenji Ohgane, Kosuke Dodo, et al.
Pageof 28

Showing results (51-60 of 271) with videos related to

Sort By:
Pageof 28
Journal of Neuroscience Research|October 23, 2002
Death and survival of neuronal cells exposed to Alzheimer's insultsTakako Niikura, Yuichi Hashimoto, Hirohisa Tajima, et al.
Bioorganic & Medicinal Chemistry|January 7, 2020
Luciferase-based HMG-CoA reductase degradation assay for activity and selectivity profiling of oxy(lano)sterolsIkuya Sagimori, Hiromasa Yoshioka, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|January 26, 2020
Phosphine boranes as less hydrophobic building blocks than alkanes and silanes: Structure-property relationship and estrogen-receptor-modulating potency of 4-phosphinophenol derivativesHiroki Saito, Yuichiro Matsumoto, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2011
Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related α-glucosidase inhibitors and liver X receptor antagonistsKazunori Motoshima, Kazuyuki Sugita, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|April 26, 2011
Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivityKazunori Motoshima, Minoru Ishikawa, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|April 3, 2012
Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2Takashi Misawa, Hisamitsu Hayashi, Yuichi Sugiyama, et al.
Biochemical and Biophysical Research Communications|February 27, 2010
TAG-1 is an inhibitor of TGFbeta2-induced neuronal death via amyloid beta precursor proteinNobuyuki Tachi, Yuichi Hashimoto, Mikiro Nawa, et al.
Chemical Communications (Cambridge, England)|September 20, 2008
Sequence-specifically platinum metal deposition on enzymatically synthesized DNA block copolymerAya Tanaka, Yasutaka Matsuo, Yuichi Hashimoto, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonistsKazunori Motoshima, Minoru Ishikawa, Kazuyuki Sugita, et al.
Bioorganic & Medicinal Chemistry|July 9, 2013
Structure-activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effectFumika Karaki, Kenji Ohgane, Kosuke Dodo, et al.
Pageof 28